The Active Pharmaceutical Ingredient (API) Market report delivers crucial insights into the market's growth trajectory and the primary revenue drivers anticipated between 2025 and 2034. As industries ...
To continue to help customers address the rapidly evolving cyber threat landscape, A10 Networks (ATEN) has acquired the ...
FDA slaps China-based API makers with separate warning letters outlining quality, testing shortfalls
A pair of Chinese manufacturers with active pharmaceutical ingredients that were previously shipped to the U.S. | The FDA ...
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Royalty Pharma (RPRX – Research Report), ...
Establishes a comprehensive, fully integrated containment solution that seamlessly connects early-phase development through ...
Deborah McElhone, Head of Sustainability (Pharma) from CPI, argues that process intensification is a game changer for the ...
The pharma sector anticipates enhanced incentives for domestic API and biosimilar production to reduce import dependency. To truly elevate India’s healthcare ecosystem, three critical areas ...
Chinese API manufacturers Wuhu Nuowei Chemistry and Chengdu Innovation Pharmaceutical have been placed on US import alert ...
Exploring sustainable blister packaging from the lens of material selection, quality regulations, machinability, and ...
Special Counsel Says ICON CEO Steve Cutler says trial activity has been “impacted by cautious spending from biopharma customers in both the biotech and large pharma businesses.” The company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback